This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Relationship: 2477
Title
Decreased, atRA concentration leads to Disrupted, meiotic initiation in oocyte
Upstream event
Downstream event
Key Event Relationship Overview
AOPs Referencing Relationship
| AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding | Point of Contact | Author Status | OECD Status |
|---|---|---|---|---|---|---|
| Decreased ALDH1A (RALDH) activity leading to decreased fertility via disrupted meiotic initiation of fetal oogonia | adjacent | Moderate | Low | Terje Svingen (send email) | Under development: Not open for comment. Do not cite | Under Development |
Taxonomic Applicability
Sex Applicability
| Sex | Evidence |
|---|---|
| Female | High |
Life Stage Applicability
| Term | Evidence |
|---|---|
| Foetal | High |
Key Event Relationship Description
All-trans retinoic acid (atRA) is the active metabolite of vitamin A and is involved in regulating a large number of developmental processes (Bushue & Wan, 2010; Ghyselinck & Duester, 2019). atRA is produced in spatial and temporal gradients, and these patterns are maintained by regulated expression of the synthesis and degradation enzymes of the atRA pathway (Kedishvili, 2013).The presence of atRA in the fetal ovaries induces germ cells to enter meiosis (Spiller et al, 2017). The initiation of meiosis at this time during fetal life is critical for maintenance of the germ line throughout development and establishment of the oocyte pool at birth. If atRA is not present at the correct time and at sufficient concentration, meiotic initiation is either delayed or prevented from occurring, ultimately disrupting germ cell development.
All-trans retinoic acid (atRA) is the active metabolite of vitamin A and is involved in regulating a large number of developmental processes (Bushue & Wan, 2010; Ghyselinck & Duester, 2019). atRA is produced in spatial and temporal gradients, and these patterns are maintained by regulated expression of the synthesis and degradation enzymes of the atRA pathway (Kedishvili, 2013).
Evidence Collection Strategy
A broad search was initially performed in PubMed (15-06-2021) using search terms “Retinoic acid AND meiosis AND ovary”, resulting in 100 publications. Based on Title and Abstract screening, retrieved publications were sorted into three categories: ‘relevant’, ‘maybe relevant’ and ‘not relevant’. Papers in the ‘maybe relevant’ category were further screened by whole article reading and subsequently categorized as ‘relevant’ or ‘not relevant’. A total 39 articles were deemed relevant for this KER.
Evidence Supporting this KER
The majority of evidence for this KER comes from rodent studies. In pregnant rats, depletion of vitamin A, the precursor of atRA, leads to an inability of ovarian germ cells to initiate meiosis (Li & Clagett-Dame, 2009). Further studies in mice have produced strong evidence that atRA acts as a meiosis-inducing factor in oogonia of the ovaries, although there are some conflicting data depending on which techniques are used (Griswold et al, 2012; Spiller & Bowles, 2022). Evidence for the same mechanisms in human fetal ovaries is less substantiated and there may be species differences, particularly the manner in which atRA is made available (reviewed by (Jørgensen & Rajpert-De Meyts, 2014). In humans, evidence to support the KER comes from studies using explanted ovary culture.
Biological Plausibility
In mammalian germ cells, the initiation and progression of meiosis is critically dependent on the expression of Stimulated by retinoic acid gene 8 (Stra8). In mice, deleting Stra8 leads to infertility in both males and females due to meiotic failure (Anderson et al, 2008; Baltus et al, 2006; Mark et al, 2008). What regulates the temporal expression of Stra8, and other factors (such as Rec8 and Dazl) in the germ cells is not completely clear, but there is strong evidence to support an important role for atRA (Bowles et al, 2006; Feng et al, 2021; Griswold et al, 2012; Koubova et al, 2014; Soh et al, 2015).
In the fetal mouse ovary, entry into meiosis, preceded by Stra8 expression, occurs in an overlapping anterior-to-posterior wave from E12.5 (Bowles et al, 2006; Menke et al, 2003). Stra8 is also expressed in rat oogonia at comparative developmental stages to the mouse (Liu et al, 2020). atRA can similarly upregulate Stra8 in vitro, but this is restricted to pluripotent cell lines(Feng et al, 2021; Oulad-Abdelghani et al, 1996; Wang et al, 2016). Culture of mouse skin-derived stem cells with atRA stimulates the formation of functioning gametes and improves oogonia-like cells entry into meiosis (Dyce et al, 2018; Miyauchi et al, 2017). Stra8 expression cannot be induced by atRA in non-pluripotent cell lines, nor in somatic cells in vivo (Feng et al, 2021).
Exposure of pre-meiotic tammar (marsupial) ovaries to atRA induces Stra8 expression and oogonial meiotic entry (Hickford et al, 2017). Culturing fetal mouse ovaries in the presence of atRA increases the number of meiotic oocytes (Livera et al, 2000) and the same phenomenon is observed in cultured human fetal ovaries (Jørgensen et al, 2015).
In mouse ovaries lacking the atRA synthesizing enzyme ALDH1A1, the onset of germ cell meiosis is delayed (Bowles et al, 2016). This supports a previous study showing that atRA derived from the ovary (rather than mesonephros) is sufficient to initiate meiosis in mice (Mu et al, 2013). In humans, the local synthesis of atRA by ALDH1A enzymes within the ovary may also be involved in meiotic regulation (Childs et al, 2011; Le Bouffant et al, 2010). In two recent studies looking at mouse ovaries lacking all known atRA synthesizing enzymes (Chassot et al, 2020) or RA receptors (Vernet et al, 2020), expression of Stra8 was delayed, albeit some meiosis was still observed in these mice.
Empirical Evidence
Animal models
|
Model |
Relevant observations |
Reference |
|
Vitamin A deficient (VAD) rats |
Oocytes fail to enter meiosis in ovaries of VAT rats due to atAR deficiency. Meiotic entry measured by SYCP3 expression was detected in 10% and 30% of germ cells in rats fed severely deficient (1.5ug of atRA per gram of diet) and moderately deficient (12ug of atRA per gram of diet) atRA diets, respectively, whilst controls had 70% of germ cells enter meiosis. The expression of the atRA-responsive gene, Stra8, was reduced by approximately 90% and 50% in the severely and moderately atRA-deficient ovaries, respectively, compared with the atRA-sufficient controls. |
In vitro/ex vivo
|
Study type |
Species |
Compound |
Effect Dose |
Duration |
Results |
Reference |
|
Fetal ovaries in culture |
Mouse |
WIN 18,446 (ALDH1A2 inhibitor) |
2 µM |
3-12 d |
Reduced Stra8 expression and germ cell loss. |
|
|
Fetal ovaries in culture |
Mouse |
BMS-189453 (RAR antagonist) |
1 µM |
3 d |
Reduced STRA8-positve germ cells without overall oocyte loss |
|
|
Embryonic stem cells |
Mouse |
ATRA |
100 nM |
Activates meiosis-related gene network |
||
|
Embryonic stem cells |
Mouse |
BMS-493 (RAR antagonist) |
10 µM |
Inhibition of expression meiosis-related genes |
||
|
Naked oocytes, matured |
Mouse |
ATRA |
2 µM |
24 h |
Culture in presence of atRA increased meiosis resumption and formation of metaphase II oocytes |
|
|
fetal ovaries in culture |
Human |
ATRA |
1 µM |
1-3 d |
atRA strongly promote initiation of germ cell meiosis |
|
|
fetal ovaries in culture |
Human |
BMS-189453 (RAR antagonist) |
10 µM |
14 d |
Partial inhibition of meiotic entry of germ cells |
|
|
fetal ovaries in culture |
Human |
Citral |
55 µM |
14 d |
Partial inhibition of meiotic entry of germ cells by inhibiting RA synthesizing enzymes |
|
|
Fetal ovaries in culture |
Mouse |
AGN193109 (RAR antagonist) |
5 µM |
48 h or 72 h |
Meiotic program inhibited |
|
|
Fetal ovaries in culture |
Mouse |
BMS-204493 (RAR antagonist) |
5 µM |
2 d |
Stra8 expression not upregulated in germ cells, marker for failed initiation of meiosis |
|
|
Fetal ovaries in culture |
Mouse |
ATRA |
1 µM |
Acceleration of germ cells into meiosis, reduction in total number of germ cells |
||
|
Fetal ovaries in culture |
Mouse |
CD0336 (RARα agonist) |
1 nM |
Acceleration of germ cells into meiosis, reduction in total number of germ cells |
||
|
Naked oocytes, matured |
Camel |
ATRA |
20 µM |
24 h |
Stimulates meiosis and promotes oocyte viability |
|
|
Fetal ovaries in culture |
Chicken |
ATRA |
1 µM |
Stimulates meiotic initiation. |
Uncertainties and Inconsistencies
Mouse deletion models for the atRA synthesis enzymes Aldh1a1, Aldh1a2 and Aldh1a3 showed decreased expression of Stra8 in double (Aldh1a2/3) and triple (Aldh1a1/2/3) knockouts, although ultimately some germ cells were observed undergoing meiosis in these ovaries, suggesting that atRA is not essential for meiotic onset or progression(Chassot et al, 2020; Kumar et al, 2011). Similarly, transgenic mice lacking the three atRA nuclear receptors (RAR-α, -β, -γ) showed reduced levels of Stra8, although ultimately some germ cells were observed undergoing meiosis and were capable of producing live offspring (Vernet et al, 2020). Whether or not these models led to impaired fertility (such as sub-fertility) has not been elucidated and the size of their oocyte pools were not determined. In addition, the completeness of the genetic deletions in these models is not clear (discussed in (Spiller & Bowles, 2022)).
Gain of function mouse ovary models for CYP26A1 and CYP26B1 show that CYP26B1 can prevent oocytes from entering meiosis (as assessed by failure to induce Stra8 expression), whereas CYP26A1 does not have the same effect despite being a potent atRA degrading enzyme. This suggests that CYP26B1 works by additional mechanism(s) other than RA degradation (Bellutti et al, 2019).
Known modulating factors
No modulating factors are currently known to alter the quantitative relationship between the two KEs.
Quantitative Understanding of the Linkage
The quantitative knowledge pertaining to this KER is very limited as little is known about 1) the levels of endogenous atRA produced in the ovaries in different mammals and 2) the levels of atRA required to achieve meiotic initiation.
Response-response Relationship
In vitro and ex vivo, it has been conclusively shown that low levels (as low as 1uM) of exogenous atRA can induce germ cells to enter meiosis in mice (Bowles et al, 2010) and rats (Livera et al, 2000) and, similarly, that it is necessary to achieve meiosis in in vitro-derived oocytes via primordial germ cells (PGCs)/PGC-like cells (PGCLCs) (Miyauchi et al, 2017). Yet, its exact role in vivo is under debate.
Whilst the relative levels of endogenous atRA produced by the ovary (for any species) remains unknown, similarly, the quantitative relationship between atRA levels and induction of meiosis also remains unclear. As such, the quantitative understanding of how much atRA needs to be reduced to prevent germ cells to enter meiosis in vivo is rated low.
Time-scale
The time-scale for this KER is relatively short, limited to just a couple of days in e.g. mouse models. The induction of meiosis occurs shortly after the germ cells have colonized the ovary and occurs asynchronously (Bullejos & Koopman, 2004) (in mice this begins at E13.5 and is completed for all germ cells 2 days later at E15.5). Proliferation is halted and cells progress through leptonema, zygonema, pachynema, and arrest in diplonema of prophase I prior to birth (Zamboni, 1986). Time and duration of oogenesis varies between species, with rats the shortest duration of only 1-2 days, with other mammals such as pigs, cows, monkeys and humans lasting months (Peters, 1970).
The rat model of vitamin A deficiency (VAD) revealed severe defects to meiosis induction when Vitamin A was restricted/removed from the diet at E10.5, which is just 3 days prior to normal meiotic induction (Li & Clagett-Dame, 2009). Shorter time-frames have not been assessed to date, nor has rescue of VAD during later embryonic time-points been attempted.
Known Feedforward/Feedback loops influencing this KER
During development, retinoic acid homeostasis is regulated by feedback loops, as both too much and too little RA can have deleterious effects on the embryo or fetus. The availability of atRA is regulated locally by maintaining a balance between synthesis (ALDH1 enzymes) and metabolism (CYP26 enzymes) (Kedishvili, 2013; Niederreither & Dollé, 2008; Roberts, 2020; Teletin et al, 2017).
The expression of Aldh1a2 and Cyp26a1 can act as part of a negative feedback loop in response to changes in RA levels. Exogenous atRA suppresses expression of Aldh1a2 (Niederreither et al, 1997) whereas blocking atRA signalling increases expression of Aldh1a2. Although Cyp26 expression does not require atRA, addition of atRA greatly increases the expression of Cyp26a1, and conversely, reduced levels of atRA reduces Cyp26a1 expression (de Roos et al, 1999; Hollemann et al, 1998; Ross & Zolfaghari, 2011; Sirbu et al, 2005). Negative feedback loops also extend to the enzymes that convert retinol to all-trans retinaldehyde as well as other related enzymes (Feng et al, 2010; Strate et al, 2009), including Ski, which seem to have cell-type specific roles (Melling et al, 2013; Niederreither & Dollé, 2008).